Simplifying Global Compliance
FDA Panel Votes to Recommend More Restrictions on Hydrocodone Combos
An FDA advisory panel voted 19–10 Friday to recommend up-scheduling hydrocodone combination products to schedule II controlled substances, a move that would bring tighter restrictions on the opioid painkillers.
To View This Article:
Subscribe To Generic Line
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing